Columbia Partners Investment Management’s AbbVie ABBV Stock Holding History

Columbia Partners Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-10,120	Closed	-$899K	–	217
2017 Q3	$899K	Buy	+10,120	New	+$770K	0.12%	167
2016 Q3	–	Sell	-20,145	Closed	-$1.25M	–	298
2016 Q2	$1.25M	Sell	20,145 -214	-1%	-$13K	0.09%	247
2016 Q1	$1.16M	Buy	20,359 +256	+1%	+$14.3K	0.08%	237
2015 Q4	$1.19M	Buy	20,103 +1,766	+10%	+$102K	0.08%	225
2015 Q3	$997K	Buy	18,337 +11,161	+156%	+$727K	0.07%	250
2015 Q2	$482K	Sell	7,176 -9,478	-57%	-$619K	0.03%	258
2015 Q1	$974K	Sell	16,654 -908	-5%	-$54.9K	0.05%	234
2014 Q4	$1.15M	Buy	+17,562	New	+$1.11M	0.06%	239
2013 Q4	–	Sell	-23,466	Closed	-$1.05M	–	314
2013 Q3	$1.05M	Buy	23,466 +704	+3%	+$31.2K	0.05%	244
2013 Q2	$940K	Buy	+22,762	New	+$996K	0.04%	252

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Columbia Partners Investment Management's ABBV Position: Q4 2017 in Review

Columbia Partners Investment Management sold out of AbbVie (ABBV) in Q4 2017, closing a stake of 10,120 shares — an estimated $899K sold.

Columbia Partners Investment Management first reported a position in ABBV in Q2 2013 and held it in 10 quarters. The position peaked at $1.25M in Q2 2016. 2,001 funds tracked by Wall St. Rank hold ABBV as of Q4 2017.

Columbia Partners Investment Management reported no remaining AbbVie position as of Q4 2017 after selling out during the quarter.
Columbia Partners Investment Management sold 10,120 AbbVie shares in Q4 2017, an estimated $899K.
Columbia Partners Investment Management first reported a position in AbbVie in Q2 2013 and held it in 10 quarters.
Columbia Partners Investment Management's AbbVie position peaked at $1.25M in Q2 2016.
2,001 funds tracked by Wall St. Rank held AbbVie as of Q4 2017.

Based on Columbia Partners Investment Management's 13F filing for Q4 2017, filed 12 Feb 2018.